Merritt Rebecca, Hayman Michael J, Agazie Yehenew M
Department of Biochemistry and Molecular Pharmacology and The Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, WV 26506-9142, USA.
Biochim Biophys Acta. 2006 Jan;1763(1):45-56. doi: 10.1016/j.bbamcr.2005.11.013. Epub 2005 Dec 20.
Most classical phosphotyrosyl phosphatases (PTPs), including the Src homology phosphotyrosyl phosphatase 2 (SHP2) possess a Thr or a Ser residue immediately C-terminal to the invariant Arg in the active site consensus motif (H/V-C-X5-R-S/T), also known as the "signature motif". SHP2 has a Thr (Thr466) at this position, but its importance in catalysis has not been investigated. By employing site-directed mutagenesis, phosphatase assays and substrate-trapping studies, we demonstrate that Thr466 is critical for the catalytic activity of SHP2. Its mutation to Ala abolishes phosphatase activity, but provides a new substrate-trapping mutant. We further show that the nucleophilic Cys459 is not involved in substrate trapping by Thr466Ala-SHP2 (T/A-SHP2). Mutation of Thr466 does not cause significant structural changes in the active site as revealed by the trapping of the epidermal growth factor receptor (EGFR), the physiological substrate of SHP2, and by orthovanadate competition experiments. Based on these results and previous other works, we propose that the role of Thr466 in the catalytic process of SHP2 could be stabilizing the sulfhydryl group of Cys459 in its reduced state, a state that enables nucleophilic attack on the phosphate moiety of the substrate. The T/A-SHP2 harbors a single mutation and specifically interacts with the EGFR. Since the nucleophilic Cys459 and the proton donor Asp425 are intact in the T/A-SAHP2, it offers an excellent starting material for solving the structure of SHP2 in complex with its physiological substrate.
大多数经典的磷酸酪氨酸磷酸酶(PTP),包括Src同源磷酸酪氨酸磷酸酶2(SHP2),在活性位点共有基序(H/V-C-X5-R-S/T)(也称为“特征基序”)中,其不变的精氨酸紧邻的C末端具有一个苏氨酸或丝氨酸残基。SHP2在该位置有一个苏氨酸(Thr466),但其在催化中的重要性尚未得到研究。通过定点诱变、磷酸酶测定和底物捕获研究,我们证明Thr466对SHP2的催化活性至关重要。将其突变为丙氨酸会消除磷酸酶活性,但会产生一种新的底物捕获突变体。我们进一步表明,亲核性的半胱氨酸459不参与Thr466Ala-SHP2(T/A-SHP2)对底物的捕获。如通过SHP2的生理底物表皮生长因子受体(EGFR)的捕获以及原钒酸盐竞争实验所揭示的,Thr466的突变不会在活性位点引起显著的结构变化。基于这些结果和之前的其他研究,我们提出Thr466在SHP2催化过程中的作用可能是稳定处于还原状态的半胱氨酸459的巯基,这种状态能够对底物的磷酸基团进行亲核攻击。T/A-SHP2含有一个单一突变,并且与EGFR特异性相互作用。由于亲核性的半胱氨酸459和质子供体天冬氨酸425在T/A-SAHP2中是完整的,它为解析SHP2与其生理底物复合物的结构提供了一个极好的起始材料。
Biochim Biophys Acta. 2006-1
Biochem Biophys Res Commun. 2006-12-29
Cell Chem Biol. 2017-4-20
Antioxid Redox Signal. 2014-5-10
J Biol Chem. 2009-5-1